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ABSTRACT 
Ischemia and reperfusion (I/R) leads to oxidative stress with free radical formation. With 
respect to liver surgery and transplantation this can lead to deleterious clinical effects. 
Protection of the liver against I/R injury is of major concern. Thus, in this study, we examined 
the effect of an antioxidant vitamin solution (vitamin E, C and ß-carotene) on warm I/R 
injury.  Twelve pigs of the German landrace (7 animals in the vitamin group and 5 untreated 
controls) were examined in this animal model. Twenty-four hours before laparotomy, the 
vitamin group was initiated with a single intravenous infusion of the vitamin cocktail. The 
duration of complete warm ischemia of the liver was 4 hours. Serum liver enzyme levels 
(AST and ALT) and with thiobarbituric acid reacting substances (TBARS) in liver tissue were 
measured. Furthermore, immunohistochemical staining of oxidative products (oxidized 
proteins and 4-hydroxy-nonenal = 4-HNE) in liver tissue was made. The maximum 
accumulation of oxidized proteins was seen six days postoperatively in the controls whereas 
in the vitamin group only small amounts were seen. 4-HNE showed a marked accumulation in 
the controls but was almost not detectable in the vitamin group. TBARS were lower in the 
vitamin group compared to controls. Although the emulsifier necessary for the vitamin 
solution leads to increased liver enzyme levels in the vitamin group, the values returned to 
normal more rapidly. Antioxidant vitamins are able to improve warm I/R liver injury. 
Oxidative stress is directly verifiable at the tissue level. Future animal experiments as well as 
clinical trials are necessary to explore the optimization of the combination of antioxidative 
vitamins for the maximum protection from I/R injury. 
 
Key words: Ischemia and reperfusion - liver – oxidative stress – antioxidative vitamins.  
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INTRODUCTION 
Ischemia and reperfusion (I/R) induces 
oxidative stress with free radical formation. 
(Serracino-Inglott et al., 2001, Cutrìn et al., 
2002). From clinical and experimental data it 
is assumed that this leads to an increased 
consumption of antioxidants resulting in an 
imbalance of the antioxidant system. 
(Barsacchi et al., 1992, Biasi et al., 1995, 
Giakoustidis et al., 2001, Salvemini et al., 
2002, Cuzzocrea et al., 2001). In liver 
surgery I/R induced oxidative stress caused 
by the temporary cross clamping of the portal 
vein and hepatic artery is considered to play 
an important role not only for injury of the 
remaining liver but also for the clinical 
outcome of patients. With respect to liver 
transplantation a marked I/R injury can lead 
to graft failure. This can result in deleterious 
clinical problems. Furthermore, free radicals 
are known to be responsible for the 
development of postoperative complications. 
Clinical studies indicate that a loss of 
antioxidants is associated with an increased 
risk for sepsis and multi-organ failure (Leff 
et al., 1993, Metnitz et al., 1999). A major 
concern in liver surgery and transplantation 
has been liver protection. 
 
Endothelial cells represent one of the main 
targets of free radicals. Oxidative stress 
induces morphological and biochemical 
alterations of these cells. (Cuzzocrea et al., 
2001, Molyneux et al., 2002). This 
contributes to damage of the entire organ. 
Administration of vitamins with 
antioxidative properties are able to minimize 
or prevent this damage (Marubayashi et al., 
1986, lehr et al. 1998). Indeed, experimental 
and clinical studies have shown positive 
effects of antioxidant vitamins on I/R injury 
of the liver (Marubayashi et al., 1989, Rabl et 
al., 1993, Cerwenka et al., 1998, Bartels et 
al., 2004). 
 
Vitamin E (= α-tocopherol) is considered to 
be the most important fat soluble antioxidant 
in cell membranes. It prevents lipid 
peroxidation-induced destabilization of the 
cell membrane by breaking the lipid radical 
chain reaction. Consequently, high cellular α-
tocopherol concentrations might increase the 
endothelial antioxidant defence and function. 
Vitamin C was shown to be protective in 
cardiac surgery with I/R, (Dingchao et al., 
1994) and is important for the regeneration of 
α-tocopherol. In case of vitamin C 
supplementation, a sufficient concentration 
of vitamin E is necessary and vice versa. β-
carotene is able to inactivate ”singulette” 
oxygen and peroxyl radicales. 
 
The purpose of the present animal 
experimental study was to evaluate whether 
the parenteral administration of an 
antioxidant solution consisting of α-
tocopherol, ascorbic acid, and β-carotene has 
beneficial effects on warm I/R liver injury. 
METHODS 
The animal experiments presented were 
confirmed by the Bezirksregierung 
Hannover, Germany (TS 94-711). 
 
Twelve female pigs of the German landrace 
served as experimental animals. All the 
animals were held in the central animal 
laboratory of the Hannover University 
School of Medicine in single boxes (2,7 m2). 
The mean body weight was 30-35 kg. The 
animals were fed with commercially 
available animal nutrition HG HY (RHG 
Nord AG, Hannover, Germany). All animals 
were administered prophylaxis against 
endoparasites with Rintal®. One week before 
the intended operation stool specimens were 
investigated concerning ascarides, oxyures, 
band worms, hawk worms, and salmonellas. 
The animals were divided into two study 
groups. The vitamin group (7 animals) 
received the vitamin solution i.v. 24 hours 
preoperatively. The control group (5 animals) 
was not treated.  
 
Vitamin solution 
The vitamin solution was designed in 
cooperation with Prof. Dr. Biesalski, 
Department of Biological Chemistry and 
Nutritional Sciences, University of 
Hohenheim, Stuttgart, Germany: 
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100 mg α-tocopherol / kg BW 10 mg β-carotene / kg BW 200 mg ascorbate / kg BW 
 
According to these recommendations the solution was prepared by BASF AG, Ludwigshafen, 
Germany: 
2,5 % α-Tocopherol 
0,25 % β-Carotene (0,08 % all trans and 0,15 % cis Isomere) 
5 % Ascorbic acid 
26 % Solutol HS 15 (emulsifier) 
2,7 %  Miglycol 812 
0,005 % 2-Ethylmercurimercaptobenzoe acid (preservation) 
1,3 % NaOH (for pH-adjustment: pH = 6)  
 
The solution was mixed with H2O 1:2 
resulting in an osmolarity of 304 mosmol/kg. 
120 ml vitamin solution with 240 ml H2O 
was administered. Thus, each animal 
received 3000 mg α-tocopherol, 300 mg β-
carotene, and 6000 mg ascorbic acid. 
Because of severe side effects, i.e. 
tachycardia and hyperthermia, when giving 
the solution without vitamins, it was decided 
to perform the study with an untreated 
control group rather than a control group 
administered solution without vitamins. 
 
Anaesthesia 
Premedication was carried out by the i.m. 
administration of 10 mg/KG body weight 
Azaperon (Stresnil®) and 0.025 mg 
Atropinsulfate (Atropinsulfat Braun®). After 
15 minutes the intubation anaesthesia was 
infused via an intravenous line: 0.005 mg/KG 
body weight Fentanyldihydrogencitrate 
(Fentanyl Janssen®) and 12.5 mg/KG body 
weight Thiopentalsodium (Trapanal®). 
Following this animals were orally intubated. 
The animals were mechanically ventilated 
using a mixture of N2O:O2 (2:1; frequency 
12/min., inspiration volume 400 ml). The 
maximal airway pressure was 20 mm Hg. 
The arterial pCO2 was 36 mm Hg during 
mechanical ventilation. Additionally, 
Isofluran was administered using a 
concentration of 1 to 2 %. Analgesia during 
the operative procedure was achieved by the 
application of Fentanyl in proportions of 
0.0025 mg/kg body weight. 1000 ml Ringer´s 
solution and 2000 ml HAES 6 % were 
infused via a central venous line. These 
amounts were necessary to avoid circulatory 
depression during hilus occlusion. 
Catecholamines were not administered in 
order to maintain microcirculation. Acidosis 
was treated by NaHCO3 and by increasing 
the respiratory frequency. 
 
Operative Procedure 
According to the literature pigs are able to 
survive hilus occlusion only for a maximum 
of 60 minutes (Battersby et al., 1974, Harris 
et al., 1982, Bredt et al., 1997). Therefore, an 
extracorporal active shunt was created in 
order to achieve longer periods of hilus 
occlusion, and to aggravate ischemia-
reperfusion injury (fig. 1). 
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Fig. 1 Experimental design. Total vascular occlusion of the liver. Extracorporal bypass. 
(BP=blood pressure, ECG=electro cardio graphie, CVP=central venous pressure, 
PAP=pulmonal arterial pressure, PAWP=Pulmonal arterial wedge pressure, 
PVP=portal venous pressure, SHCV=suprahepatic caval vein, HA=hepatic artery, 
PV= portal vein, IHCV=infrahepatic caval vein) 
 
In a first step the internal carotid artery, 
internal and external jugular veins were 
prepared. Blood pressure was continuously 
monitored via a carotid arterial catheter. The 
external jugular vein was used for the venous 
part of the shunt. Via the internal jugular vein 
a pulmonary artery catheter was introduced 
for measurement of central venous pressure, 
pulmonal artery pressure and pulmonal artery 
wedge pressure. 
 
In a second step the animals were 
laparotomized. The hepatic artery and 
branches thereof, the portal vein as well as 
the supra- and infrahepatic caval vein were 
prepared. The portal part of the shunt was 
introduced into the portal vein. A further 
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shunt was created between the common iliac 
vein and the internal jugular vein for 
standardization of the hemodynamic situation 
(fig. 1). Thereafter, the hepatic artery, the 
portal vein as well as the supra- and 
infrahepatic caval vein were selectively 
cross-clamped in order to achieve a total 
vascular occlusion of the liver. For the 
extracorporal circulation a Gott aneurysma 
shunt and a so-called biopump were used 
(Biomedicus, Minneapolis, Minnesota). The 
flow was 30 ml/min/kg body weight. Under 
these conditions the portal venous pressure 
was 2-5 mm Hg corresponding to 
physiological values in pigs. After an 
ischemic period of four hours the clamps as 
well as the shunt were removed. The 
abdomen and cervix were closed. The 
animals were extubated. Analgesia was 
performed with Piritramid 5 mg (Dipidolor®) 
whenever necessary. After a period of six 
days the animals were sacrificed using T61 
ad us vet.® (0.2 g Embutramid, 0.05 g 
Mebezoniumjodid, 0.005 g 
Tetracainhydrochlorid / ml). 
 
Blood and tissue sampling 
Blood samples for serum analyses and  
wedge liver biopsies (0.5x0.5cm) for the 
measurement of TBARS as well as for 
histological and immunohistochemical 
evaluation were taken at defined time points. 
(Table 1) Serum values of different enzymes 
AST, ALT, GLDH) as well as liver function 
parameters (serum bilirubin, coagulation 
parameters) were measured. 
 
 Preoperativ
ely 
B
efore 
ischem
ic 
periodO
P
 
E
nd of 
ischem
ic 
period 
5 m
inutes 
after 
reperfusion 
30 m
in 
after 
reperfusion 
1 hour after 
reperfusion 
3 hours 
after 
reperfusion 
1 day 
postoperati
vely 
3 days 
postoperati
vely 
6 days 
postoperati
vely 
AST X  X X X X X X X X 
ALT X  X X X X X X X X 
GlDH X  X X X X X X X X 
Histology/
TBARS 
 X X  X X    X 
 
Table 1: Time points of blood and tissue sampling. 
 
Histology / Immunohistochemistry in liver 
tissue 
Oxidized proteins 
Protein oxidation is characterized by the 
insertion of additional carbonyl groups into 
the molecule. The molecule 2.4-
dinitrophenylhydrazin (2.4-DNPH) is able to 
bind to protein bound carbonyl groups. 2.4-
dinitrophenylhydrazon (DNPH) emerges and 
can be visualized with an anti-DNPH-
antibody by indirect immunhistological 
staining. 
Frozen sections of liver tissue (5μm) were 
fixed in a mixture of diethylether and ethanol 
(1:1) at room temperature. Incubation 
followed in 2.4-DNPH solution (300 mg 
DNPH in acid 95% ethanol over night at 
room temperature). Following the incubation 
the sections were washed in 95% acid 
ethanol and rehydrated in decreasing 
concentrations of alcohol. After this, ligands 
of possible cross reaction were blocked with 
sheep’s serum (1:10). The incubation with a 
canine-anti-dinitrophenyl-antibody (1:200, 
DAKO) was performed at 4°C for two hours. 
Following this, the sections were incubated 
with a peroxidase conjugated sheep-anti-
canine-antibody (1:100, Boehringer) for one 
hour at room temperature. After each 
 157
antibody incubation the sections were 
washed with Tris/NaCl buffer (pH=7.4). 
Aminoethylcarbazol (Sigma) in N,N-
dimethylformamide and sodium acetate (0,1 
m) served as substrate for the peroxidase (15 
min). Finally, the sections were stained with 
Mayr’s haemalaun (Merck). The negative 
control was not incubated with the primary 
antibody. 
 
4-hydroxy-nonenal 
4-hydroxynonenal (4-HNE) represents a 
metabolite developing as a consequence of 
lipid peroxidation and is regarded as a 
specific marker of oxidative stress. 
Frozen sections (5μm) were fixed in cold 
acetone, washed with PBS-solution and 
incubated with sheep’s serum. The sections 
were incubated with the primary monoclonal 
mouse 4-HNE-antibody 1g4h7 (1:50, Dr. 
Waeg, Institute for Biochemistry, University 
of Graz, Austria) for 1 hour at 37°C. 
Incubation with a peroxidase conjugated 
sheep anti-mouse-antibody followed (1:25, 
Boehringer) for 1 hour at room temperature. 
The sections were washed with PBS-solution 
(pH:7.4). Corresponding to the method 
described above aminoethylcarbazol served 
as substrate for the peroxidase. Finally, the 
sections were stained with Mayr’s 
haemalaun. The negative control was not 
incubated with the primary antibody.  
 
TBARS (Thiobarbituric acid reacting 
substances) 
In addition to malondialdehyde (MDA), 4-
HNE and other metabolites develop as a 
consequence of lipid peroxidation. These 
metabolites bind to thiobarbituric acid, and 
are therefore called thiobarburic acid reacting 
substances (TBARS). The products can be 
quantitatively measured by fluorescence 
spectrometry and are considered to 
correspond to the amounts of protein 
measured in the same tissue: μmol MDA 
equivalents /g protein. 
20 frozen sections (20 μm) were incubated in 
250 μl lyse buffer for two hours on ice. Lysis 
buffer consisted of 10 mM tris buffer 
(pH7.4), 0.9% Nonidet P-40 (Sigma) 0.1% 
Sodium Dodecyl Sulfate (Sigma) and 
benzonase (0.25 U/μl buffer, Sigma). 
Subsequently, the samples were centrifuged 
at 4°C for 5 minutes (10000xg). 40 μl and 
200 μl were taken for measurement of 
protein concentration and for TBARS, 
respectively. 
 
200 μl of the lysate or of MDA-standard was 
mixed with 10 μl hydroxytoluol in ethanol 
(0.227 M) and 200 μl ortho-phosphoric acid. 
Incubation with 25 μl thiobarbituric acid 
reagent (800 mg thiobarbituric acid in 50 ml 
0.1 M NaOH) at 90°C for 45 minutes 
followed. TBA-adducts were extracted with 
1-butanole and 50 μl saturated NaCl solution 
and centrifuged for 1 minute (12000 
rounds/min). 200 μl of the above butanole 
phase was introduced in 96 well flat-bottom 
microtiter plate. TBARS emission was 
measured at 590 nm in a fluorescence-
ELISA-reader (Titertek Fluoroscan II). 
 
A commercially available colourimetric 
assay was used for the measurement of 
protein concentration (Bio-Rad DC Protein 
Assay, Bio-Rad). 
 
Statistical analysis 
The Wilcoxon-Mann-Whitney-U-test was 
used for statistical data analysis. Statistical 
significance was reached at values for 
p<0.05. 
 
RESULTS 
Immunohistochemistry 
Oxidized proteins 
Control group: An intracellular accumulation 
with periportal accentuation was seen at the 
preischemic time point with no change 
during the ischemic period. In the reperfusion 
period the intracellular accumulation 
increased predominantly confined to the 
central vein after 30 minutes (fig. 2a). After 
60 minutes the accumulation increased with 
involvement of the periportal region as well. 
The maximum accumulation occurred after 6 
days (fig. 2b).  
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Vitamin group: At the preischemic time point 
an extracellular accumulation was seen 
predominantly confined to the central vein. 
Intracellular accumulation of oxidized 
proteins was not observed. No change 
occurred during the ischemic period. 30 
minutes after reperfusion, extracellular 
accumulation increased, and occasionally 
intracellular accumulation was observed, 
predominantly confined to the periportal 
region (fig. 2b). The maximum accumulation 
became visible 60 minutes after reperfusion 
with homogenous extracellular accumulation 
in the sinusoidal spaces. After six days only 
small extracellular periportal amounts of 
oxidized proteins were detectable. There was 
a marked difference compared to the controls 
after 6 days (fig. 2d) 
 
  
2a       2b 
  
2c       2d 
 
Fig. 2 a-d Vitamin group and controls. Oxidized proteins. Indirect peroxidase staining. Counter-
staining with Mayer`s Hämalaun. 30 minutes after reperfusion: In the control group 
an intracellular accumulation of oxidised proteins is visible predominantly in the 
central region (2a, arrows, x100), whereas in the vitamin group oxidized proteins only 
are seen at the extracellular level in the periportal region (2b, arrows, x100). 6 days 
postoperatively: In controls oxidized proteins are markedly pronounced in the 
cytoplasm of hepatocytes predominantly in the periportal but also in the central region 
(2c, x100) In the vitamin group only small amounts of oxidized proteins are visible at 
the extracellular level in the periportal region (2d, x100). 
 
4-Hydroxynonenal 
Control group: At the preischemic time point 
a slight periportal accumulation was seen. 
This increased during the ischemic period. 
Cytosolic granulations occurred in the 
periportal region. 30 minutes after 
reperfusion these granulations increased 
rapidly (fig. 3a) reaching a maximum after 
60 minutes After 6 days the accumulation 
decreased, the granulations disappeared (fig. 
3c). 
 
Vitamin group: Before and after reperfusion 
no 4-HNE was detectable using the 
monoclonal antibody (fig. 3b). After 6 days 
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only very small amounts of 4-HNE were seen (fig. 3d). 
 
   
3a       3b 
   
3c       3d 
Fig. 3 a-d Vitamin group and controls. Indirect peroxidase staining of protein-bounded 4-HNE, 
counter-staining with Mayer`s Hämalaun. 30 minute after reperfusion: In the control 
group an increasing accumulation of 4-HNE in hepatocytes occured. (3a, x100). In 
contrast 4-HNE was not detected in the vitamin group (3b, x100). 6 days 
postoperatively: Small amounts of 4-HNE were visible in the periportal region in the 
control group (3c, x100) with a clear difference to the vitamin group. (3d, x100) 
 
TBARS 
Compared to the vitamin group the control 
animals had higher TBARS concentrations in 
the liver tissue (fig. 4). 
 
Enzymes 
Preoperatively, at the end of the ischemic 
period and until 6 hours after reperfusion the 
vitamin group showed higher activities of 
AST and ALT than control animals (figs. 
5,6). Between 3 and 6 hours after reperfusion 
the enzyme activity in controls nearly 
doubled, whereas in the vitamin group the 
activities showed only a slight increase 
(figs.5,6). From postoperative day 1 until 
postoperative day 6 the enzyme activities of 
AST and ALT were higher in the control 
animals (figs. 5,6). The serum activity of 
GLDH was higher until postoperative day 1 
in the vitamin group (fig. 7). Between 
postoperative day 1 and 2 the serum activity 
of GLDH rapidly decreased in the vitamin 
group whereas the GLDH activity in controls 
continued to increase (fig.7). The GLDH 
activity in controls was five-fold higher at 
postoperative days 2 and 3 compared to the 
vitamin group (fig. 7).  
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Fig. 4  TBARS in liver tissue. The controls had significantly higher TBARS at the end of the 
ischemic period. The vitamin group demonstrated lower mean TBARS values until the 
end of the experiment. * p < 0,05 
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Fig. 5  Serum activity of AST. The vitamin group values returned to normal more rapidly. * p 
< 0,05 
 
 161
0
50
100
150
200
250
300
pre
op
era
tiv
ely
en
d o
f is
ch
em
ia
5 m
in 
aft
er 
rep
erf
us
ion
30
 m
in 
aft
er 
rep
erf
us
ion
60
 m
in 
aft
er 
rep
erf
us
ion
3 h
 af
ter
 re
pe
rfu
sio
n
6 h
 af
ter
 re
pe
rfu
sio
n
po
sto
p d
ay
 1
po
sto
p d
ay
 2
po
sto
p d
ay
 3
po
sto
p d
ay
 6
A
LT
 U
/L
vitamin group control group  
Fig. 6  Serum activity of ALT. The controls demonstrate a higher peak 6 hours after 
reperfusion. ALT levels are falling in the vitamin group, while in the control group, 
levels are rising. * p < 0,05 
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Fig. 7  Serum activity of GLDH. In the vitamin group levels of GLDH returned to normal more 
rapidly. Between postoperative day 1 and 2 the serum activity rapidly decreased in 
the vitamin group whereas the GLDH activity in controls continued to increase. * p < 
0,05 
 
No differences were seen concerning 
hemodynamic parameters, or liver function 
tests, e.g. serum bilirubin level and 
coagulation parameters. 
 
DISCUSSION 
In the present animal experimental study, we 
demonstrate the positive effects of an 
antioxidant vitamin solution on hepatic 
ischemia and reperfusion injury. These 
beneficial effects are shown through both 
histological methods and by liver enzyme 
levels. Histologically, peroxidation products 
were seen at the intracellular level in the 
control group whereas the vitamin group 
showed these products predominantly at the 
extracellular level. Due to the experimental 
design in our study using an extracorporal 
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bypass it was possible to investigate the 
hepatic I/R injury excluding the influence of 
hemostasis and disturbed circulation in the 
entire gastrointestinal tract. The results 
clearly demonstrate that oxidative stress is 
directly verifiable at the tissue level. 
 
Less oxidative stress in animals treated with 
Antioxidative Vitamins 
The cytotoxic effects of oxidative stress are 
caused by the peroxidative degradation of 
membrane lipids, which results in the 
accumulation of conjugated aldehydes. 
Among the most abundant and damaging of 
these is 4-hydroxynonenal (4-HNE). 4-HNE 
accumulation has been implicated in several 
chronic disorders including Alzheimer’s and 
Parkinson’s disease as well as alcoholic liver 
disease, preeclampsia and cancer (Uchida 
2003, Sampey et al. 2003). 4-HNE therefore, 
also usefully serves as a specific biomarker 
for oxidative stress and may accumulate in 
concentrations of 10 μM – 5 mM in response 
to oxidative insult (Uchida 2001). 
Histological sections stained with 4-HNE 
lend a dramatic visual representation of the 
protective effects of antioxidative vitamins. 
Thirty minutes after reperfusion, 
accumulation of oxidized proteins is clearly 
present in the central vein of control animals, 
while at the same time in vitamin treated 
animals, oxidized proteins are found only in 
the periportal region. (fig. 2a,b). The most 
remarkable difference is visible by six days 
post-operatively. In control animals, 
numerous large blotches of oxidized proteins 
can be seen compared to none in the vitamin 
treated cohort (fig. 2 c,d). This is a clear 
visual representation of the protective effects 
of antioxidative vitamins in treated animals.  
 
Liver Enzyme Levels Demonstrate Benefit of 
Antioxidative Vitamins 
TBARS provides a measure of the amount of 
lipid peroxides formed in a sample of LDL 
cholesterol, or the amount of LDL oxidation. 
Since a loss of antioxidants is associated with 
organ failure, supplementation with 
antioxidant vitamins such as vitamin C and 
vitamin E, which can inhibit the oxidation of 
LDL cholesterol, should prove protective for 
oxidative stress. This is borne out in fig. 4, 
which demonstrates that animals that 
received infusions of antioxidant vitamins 
had significantly lower TBARS at the end of 
the ischemic period and that there was a clear 
protective or beneficial trend over the entire 
experiment in which antioxidant vitamins 
demonstrated lower mean TBARS values. 
Interestingly, in the control animals, the 
TBARS levels increase between the pre-
ischemic and end of ischemia period while in 
the same period, in the experimental animals 
TBARS decrease. 
 
Although both groups of animals had the 
same maximal rise of AST, around 1000 
U/L, and despite the higher than normal 
values in the vitamin group, the experimental 
group values returned to normal sooner 
indicating a speedier recovery, and this 
recovery occurred at more rapid rate as 
compared to the control group (fig. 5). 
Furthermore, despite initial higher values in 
the experimental group, antioxidant treatment 
had a clear beneficial effect; in that serum 
activity of ALT (fig. 6) in control animals 
demonstrate a higher peak indicating a 
greater degree of liver damage. Six hours 
after reperfusion in the vitamin treated group, 
ALT levels are falling, indicating that cells 
are recovering, while in the control group, 
levels are rising, indicating that the injury is 
continuing. These tests taken together, show 
that vitamin treated animals were protected, 
as compared to control animals. 
 
Serum levels of GLDH (fig. 7) demonstrate 
again, a rapid return to normal levels of 
GLDH in antioxidant treated animals in 
comparison to control animals between post-
op day one and two. This indicates a 
restoration of functional recovery and reveals 
the beneficial effects of pre-ischemic 
antioxidant treatment. 
 
The Solubility Problem 
Preoperatively and in the first hours after 
reperfusion, serum activity of liver enzymes 
was higher in the vitamin treated group. The 
higher enzyme concentrations preoperatively 
until postoperative day 1 can be explained 
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through the administration of the emulsifier 
Solutol HS 15 which may be toxic to liver 
tissue. Although the non-ionic surfactant 
Solutol HS 15 is an excipient approved for 
use in parenteral formulations in humans, 
detailed studies on the biodistribution of 
Solutol HS 15 in the literature remain 
incomplete (Bravo Gonzelez et al. 2004). At 
the time this study was conceived, Solutol 
HS 15 was a recommended excipient for the 
solubilization of lipid vitamins such as α-
tocopherol, furthermore, complications 
involving liver (toxic) effects of Solutol were 
not widely described. Significantly, 
according to a 2003 publication, Solutol HS 
15 cannot be considered to be an “inert 
formulation ingredient”. Rather, in clinical 
formulations, Solutol may increase the 
plasma exposure of a co-administered 
compound (increasing its toxicity) especially 
in regards to liver function (Bittner et al. 
2003). The use of the novel soybean lipid 
emulsion in a pilot study in humans 
demonstrates that these negative effects can 
be avoided, such that a patient receiving the 
vitamin infusion experiences the beneficial 
effects of the antioxidants without the 
concurrent increase in liver enzyme levels 
observed in this study, presumably caused by 
the solvent (Bartels et al. 2004). Any future 
study, looking at the effects of combined or 
separate vitamin antioxidants should avoid 
use of surface active potentially liver-
damaging excipients. 
 
Several attempts to use Solutol HS 15 
without supplemental vitamins in this 
extracorporal bypass experimental design as 
controls, resulted in marked side effects. This 
fact alone indicates the protective effects of 
antioxidative vitamins, nevertheless, 
concerns regarding side-effects lead us to 
carry out this experiment using untreated 
animals as controls. 
 
Protective Spectrum of Antioxidative 
Vitamins 
Oxidative stress is characterized by an 
imbalance of the antioxidant system with 
increased lipid peroxidation products and 
decreased antioxidants. This phenomenon 
can be observed in major surgery, and 
particularly in ischemia and reperfusion (I/R) 
injury which represents a major clinical 
problem (Muzokova et al. 2001., Ninimiya et 
al., 2004). The I/R injury may have 
deleterious effects on the clinical outcome of 
patients undergoing hepatic surgery or 
transplantation.  
Substances that scavenge or remove hydroxyl 
radicals including MCI-186, Trolox, Tempol 
and edaravone are among the promising new 
agents that have been shown to have positive 
outcomes in ameliorating the effects of 
oxidative stress in ischemia/reperfusion 
models (Eum and Lee 2004, Sepodes et al., 
2004, Abe et al., 2004, Cerwenka et al. 
1999). However, antioxidant vitamins which 
are immediately available, relatively safe and 
inexpensive have not been thoroughly 
explored as regards to their protective 
benefits in this respect. Only limited data 
exist concerning the influence of high doses 
of antioxidant vitamins on I/R injury of the 
liver under normothermic conditions. A 
positive effect on postischemic liver 
functions was shown by the administration of 
a multivitamin infusion with minor doses of 
α-tocopherol and ascorbate (Rabl et al., 
1995). Additionally, several experimental 
studies revealed a positive impact on I/R 
injury by antioxidant vitamins (Rhoden et al., 
2001, Yoshimura et al., 2002, Wijnen et al., 
2002). Specifically, vitamin C was found to 
be protective for liver injury in the rat in 
lower doses (Seo and Lee 2002). Similar 
effects were seen for dehydoascorbate, for α-
tocopherol and its combination with 
gadolinium chloride (de Tata et al., 2005, 
Lee and Lee 2005, Giakoustidis et al. 2006). 
Furthermore, antioxidant vitamins E and C in 
critically ill surgical patients reduce the 
incidence of organ failure and the length of 
stay in ICU (Nathens et al. 2002). These 
results support our placebo controlled double 
blind pilot study (Bartels et al. 2004) in 
which patients undergoing partial liver 
resection were administered infusions 
containing vitamin E one day before surgery. 
This study is the first demonstration of the 
beneficial effects of pre-operative vitamin E 
administration for patients. We describe 
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patient benefits including a significantly 
shorter intensive care-unit stay, and a swifter 
return to normal levels of ALT and AST 
levels. The trend towards more rapid 
recovery is similar in both our human and 
swine studies.  
The results from these studies lay a positive 
foundation on which to further explore the 
protective effects of antioxidant vitamins on 
ischemia and reperfusion. Furthermore, the 
availability of a non-liver-toxic excipient for 
lipid soluble antioxidative vitamins will 
support future clinical trials as well as animal 
based experiments exploring the optimization 
of the combination of antioxidative vitamins 
for the maximum protection from ischemia-
reperfusion injury. 
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